Status:
UNKNOWN
Carbetocin Versus Oxytocin in the Prevention of Post Partum Haemorrhage (PPH) in Women Undergoing Caesarean Sections for Placenta Previa: A Randomised Controlled Trial
Lead Sponsor:
Cairo University
Conditions:
Post Partum Haemorrhage
Eligibility:
FEMALE
20-40 years
Phase:
PHASE3
Brief Summary
The study aims at comparing the roles of carbetocin and oxytocin in the prevention of atonic PPH in women undergoing CS for placenta previa. 200 women will be randomly divided into 2 equal groups usi...
Detailed Description
Obstetric haemorrhage remains one of the major causes of maternal death in both developed and developing countries. Postpartum haemorrhage (PPH) is defined as a blood loss \>500 ml more of blood from ...
Eligibility Criteria
Inclusion
- Women undergoing CS for placenta previa
Exclusion
- Gestational age \<37 weeks
- Hypertension
- Preeclampsia
- Cardiac, renal or liver diseases
- Need for general anaesthesia
- Known hypersensitivity to carbetocin
- Suspected placenta accreta
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT02303418
Start Date
November 1 2014
Last Update
January 23 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
BeniSuef University hospitals
BeniSuef, Egypt
2
Cairo university hospitals
Cairo, Egypt